Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy

Diabetic Neuropathy

(2013) Aaron I. Vinik et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8–10 February 2013, Naarden, The Netherlands

(2013) Els K. Vanhoutte et al.   NEUROMUSCULAR DISORDERS

THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

(2012) Teresa Coelho et al.   CURRENT MEDICAL RESEARCH AND OPINION

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Efficacy and Safety of Antioxidant Treatment With  -Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

(2011) D. Ziegler et al.   DIABETES CARE

Familial amyloid polyneuropathy

(2011) Violaine Planté-Bordeneuve et al.   LANCET NEUROLOGY

Quality of life in patients with familial amyloidotic polyneuropathy long-term after liver transplantation

(2009) Gerda Drent et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS